Rheumatoid arthritis: still a chronic disease

被引：39

作者：

Miossec, Pierre ^{[1
]}

机构：

[1] Univ Lyon, Edouard Herriot Hosp, Dept Clin Immunol & Rheumatol, Immunogen & Inflammat Res Unit, F-69437 Lyon, France

来源：

LANCET | 2013年 / 381卷 / 9870期

关键词：

DOUBLE-BLIND; ETANERCEPT; METHOTREXATE; COMBINATION;

D O I：

10.1016/S0140-6736(12)62192-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：884 / 886

页数：4

共 13 条

[1] A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis [J].

Bathon, JM ;

Martin, RW ;

Fleischmann, RM ;

Tesser, JR ;

Schiff, MH ;

Keystone, EC ;

Genovese, MC ;

Wasko, MC ;

Moreland, LW ;

Weaver, AL ;

Markenson, J ;

Finck, BK .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) :1586-1593

[2] Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy [J].

Chen, Der-Yuan ;

Chen, Yi-Ming ;

Chen, Hsin-Hua ;

Hsieh, Chia-Wei ;

Lin, Chi-Chen ;

Lan, Joung-Liang .

ARTHRITIS RESEARCH & THERAPY, 2011, 13 (04)

[3] Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial [J].

Emery, Paul ;

Breedveld, Ferdinand C. ;

Hall, Stephen ;

Durez, Patrick ;

Chang, David J. ;

Robertson, Deborah ;

Singh, Amitabh ;

Pedersen, Ronald D. ;

Koenig, Andrew S. ;

Freundlich, Bruce .

LANCET, 2008, 372 (9636) :375-382

[4] Combination etanercept and methotrexate provides better disease control in very early (≤4 months) versus early rheumatoid arthritis (>4 months and <2 years): post hoc analyses from the COMET study [J].

Emery, Paul ;

Kvien, Tore K. ;

Combe, Bernard ;

Freundlich, Bruce ;

Robertson, Deborah ;

Ferdousi, Tahmina ;

Bananis, Eustratios ;

Pedersen, Ronald ;

Koenig, Andrew S. .

ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (06) :989-992

[5] Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial [J].

Klareskog, L ;

van der Heijde, D ;

de Jager, JP ;

Gough, A ;

Kalden, J ;

Malaise, M ;

Mola, EM ;

Pavelka, K ;

Sany, J ;

Settas, L ;

Wajdula, J ;

Pedersen, R ;

Fatenejad, S ;

Sanda, M .

LANCET, 2004, 363 (9410) :675-681

[6] Rheumatoid arthritis [J].

Klareskog, Lars ;

Catrina, Anca Irinel ;

Paget, Stephen .

LANCET, 2009, 373 (9664) :659-672

[7] Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies [J].

Miossec, P. ;

Verweij, C. L. ;

Klareskog, L. ;

Pitzalis, C. ;

Barton, A. ;

Lekkerkerker, F. ;

Reiter, S. ;

Laslop, A. ;

Breedveld, F. ;

Abadie, E. ;

Flamion, B. ;

Dere, W. ;

Mpofu, S. ;

Goel, N. ;

Ethgen, D. ;

Mitlak, B. ;

Ormarsdottir, S. ;

Rao, R. ;

Tsouderos, Y. ;

Reginster, J-Y .

ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (10) :1713-1718

[8] A Randomized Comparative Effectiveness Study of Oral Triple Therapy Versus Etanercept Plus Methotrexate in Early Aggressive Rheumatoid Arthritis The Treatment of Early Aggressive Rheumatoid Arthritis Trial [J].

Moreland, Larry W. ;

O'Dell, James R. ;

Paulus, Harold E. ;

Curtis, Jeffrey R. ;

Bathon, Joan M. ;

St Clair, E. William ;

Bridges, S. Louis, Jr. ;

Zhang, Jie ;

McVie, Theresa ;

Howard, George ;

van der Heijde, Desiree ;

Cofield, Stacey S. .

ARTHRITIS AND RHEUMATISM, 2012, 64 (09) :2824-2835

[9] Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis [J].

Nielen, MMJ ;

van Schaardenburg, D ;

Reesink, HW ;

Twisk, JWR ;

van de Stadt, RJ ;

van der Horst-Bruinsma, IE ;

de Koning, MHMT ;

Habibuw, MR ;

Dijkmans, BAC .

ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (04) :535-537

[10]

Smolen JS, 2013, LANCET, DOI org/10.1016/S0140-6736(12)61811-X

← 1 2 →